PHARMAFOCUS 2019 UPDATE
November 2015Gerry Jeffcott, Bill Dempster, Michel Parent, Rachael Manion | IMS Brogan
2015
Five Years of the pCPA — Impact and Opportunities for Industry
Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2015
Canada: The Impact on Drug Reimbursement of Healthcare System Reform in Quebec
Johanne Chambers and Dima Samaha, IMS Pharma Pricing & Reimbursement, September 2015, Vol. 20(9)
Therapeutic Reviews: Experience in Canada and Impact on Reimbursement
Johanne Chambers & William Dempster, IMS Pharma Pricing & Reimbursement, September, 2015, Vol. 19(6)
Implementation of Bill C-17 – Impact on Market Access
Bill Dempster and Rachael Manion, Provincial Reimbursement Advisor, August 2015
CADTH in Transition: Exploring Reforms to Align Reimbursement Reviews
Gerry Jeffcott and Johanne Chambers, Provincial Reimbursement Advisor, August 2015
Examining Models for a National Pharmacare Program
Bill Dempster and Gerry Jeffcott, June 18, 2015
How patient groups can have more say in the drug approval process
Bill Dempster and Johanne Chambers, February 19, 2015
Developing a Multi-Criteria Approach for Drug Reimbursement Decision Making: An Initial Step Forward
Francois Dionne, Craig Mitton, Bill Dempster, and Larry D. Lynd, Journal of Population Therapeutics and Clinical Pharmacology, February 12, 2015, Vol 22(1)
The IBM Report on the pCPA
Gerry Jeffcott and Rachael Manion, February 5, 2015